Establishment of an hepatocyte cell line derived from human amnio-blast cells and the evaluation of its functions when transplanted and orientation to artificial bio-liver apparatus.
人羊膜母细胞来源的肝细胞系的建立及其移植时的功能评估和人工生物肝装置的定位。
基本信息
- 批准号:16591274
- 负责人:
- 金额:$ 2.05万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2004
- 资助国家:日本
- 起止时间:2004 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
[Object] Although liver transplantation has become the ultimate therapy for hepatic failure patients, the lack of absolute donor organ has opened the path of development to adjuvant and/or alternative methods such as cell transplantation and artificial liver apparatus. The research to develop the material for these methods has involved fetal, embryonic stem cells and transfection, transductions of hepatocyte to become immortalized cells. But most trials are stalled due to unanswered problems involving function, tumorigensis, immunogenetic and ethical questions. The placenta is usually disposed after birth and amnion obtained from this waste expresses little MHC class I and no class II. We focused on this material that also produces other immuno-regulartory factors, hypothesizing to find immature cells that would mature into functional hepatocytes. [Methods] Human-early embryo amnion was dissected in 0.1%trypsin-0.02%EDTA/PBS (-) and cultured in growth medium (GM) containing DMEMF12+ … More 20%FBS+0.1%NEA. Small circular cells developed within the single-layered cells were cloned colonially. The cells were named HEAC cells and were used in the following experiments. HEAC cells were maintained in GM with addition of 1ng/ml of LIF. Liver failure rats were created chemically using carbon tetrachloride with the survival rate of 33%. Cells were transplanted into these rats to investigate on their protrombin time, serum albumin levels and also survival rate. Also they were cultured in collagen type 1 to characterize the differentiated cells in 3-dimension culture. [Results] Amnion cells are fairly small cells with immature cytoplasm and active differentiation potency. After several regulations the cytoplasm becomes rich with various organelle, evolving the cells to differentiate. Within the collagen sponge 3-dimention culture the cells produced Albumin, a typical characteristic of a hepatocyte. When transplanted into chemically induced liver failure rats, it improved protrombin time, serum albumin levels and also survival rate up to 90%. Less
[目的]虽然肝移植已成为肝功能衰竭患者的终极治疗方法,但由于缺乏绝对供体器官,为细胞移植和人工肝器等辅助和/或替代方法的发展开辟了道路。为这些方法开发材料的研究涉及胎儿、胚胎干细胞和肝细胞的转基因,转导成为永生化细胞。但大多数试验由于涉及功能、肿瘤发生、免疫遗传学和伦理问题的悬而未决的问题而停滞不前。胎盘通常在出生后被处理,从这些废物中获得的羊膜表达很少的MHC I类和没有II类。我们专注于这种物质,它还会产生其他免疫调节因子,假设寻找能够成熟为有功能的肝细胞的未成熟细胞。[方法]人早期胚胎羊膜在0.1%胰酶-0.02%EDTA/PBS(-)中分离,在含有DMEMF12+…的生长液中培养。20%以上的FBS+0.1%的NEA。对单层细胞内发育的小环状细胞进行克隆。这些细胞被命名为HEAC细胞,并用于以下实验。在GM中加入1 ng/mlLIF维持HEAC细胞。用四氯化碳化学法复制大鼠肝衰竭模型,存活率为33%。将细胞移植到这些大鼠体内,观察它们的原凝血酶时间、血清白蛋白水平以及存活率。并将其在1型胶原中培养,在三维培养中对分化细胞进行鉴定。[结果]羊膜细胞体积较小,胞质未成熟,分化能力较强。经过几次调节后,细胞质变得富含各种细胞器,使细胞进化分化。在胶原海绵三维培养中,细胞产生白蛋白,这是肝细胞的典型特征。将其移植到化学性肝衰竭大鼠体内,可改善原凝血酶时间、血清白蛋白水平,存活率高达90%。较少
项目成果
期刊论文数量(28)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Embryonic Stem(ES)細胞より樹立したインスリン分泌細胞と糖尿病ラットへの移植
从胚胎干细胞(ES)建立胰岛素分泌细胞并移植到糖尿病大鼠体内
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:田部井 功、石渡 勇、大井 聡;他
- 通讯作者:他
Characteristics of hepatocytes derived from early ES cell and treatment of surgically induced liver failure rats by transplantation
早期ES细胞来源肝细胞的特性及移植治疗手术性肝衰竭大鼠
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:I.;Tabei;H.;Hashimoto;I.;Ishiwata;T.;Tachibana;S.;Ohi;H.;Kubo;K.;Satou;Y.;Yamazaki;K.;Yanaga;H.;Ishikawa
- 通讯作者:Ishikawa
Treatment Of Diabetic Rats With Islet-Like Cells Derived From Early Embrionic Stem Cell And Establishing Insulin Secreating Cell Line
早期胚胎干细胞胰岛样细胞治疗糖尿病大鼠并建立胰岛素分泌细胞系
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:I. Tabei;H. Ishikawa;他
- 通讯作者:他
Differentiation of nervous cells derived from human amniotic cells cultured with retinoic acid
视黄酸培养的人羊膜细胞衍生的神经细胞的分化
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:田部井 功、石川 博;他
- 通讯作者:他
レチノイン酸添加培養による人羊膜細胞の神経系細胞への分化
添加视黄酸培养人羊膜细胞向神经系统细胞分化
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:田部井 功;石渡 勇;黒田勇二他
- 通讯作者:黒田勇二他
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TABEI ISAO其他文献
TABEI ISAO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Amnion cell secretome mediated therapy for traumatic brain injury
羊膜细胞分泌组介导的创伤性脑损伤治疗
- 批准号:
10746655 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Amnion cell therapy for acute and chronic stroke
羊膜细胞疗法治疗急性和慢性中风
- 批准号:
nhmrc : 2003156 - 财政年份:2021
- 资助金额:
$ 2.05万 - 项目类别:
Ideas Grants
I-ACT: Phase I trial of Amnion Cell Therapy for Ischaemic Stroke to establish the maximum tolerable dose
I-ACT:羊膜细胞疗法治疗缺血性中风的 I 期试验,以确定最大耐受剂量
- 批准号:
nhmrc : GNT1163282 - 财政年份:2019
- 资助金额:
$ 2.05万 - 项目类别:
Project Grants
Human Amnion Cell Model for Investigation of Amniotic Fluid Volume
用于研究羊水量的人类羊膜细胞模型
- 批准号:
8113659 - 财政年份:2011
- 资助金额:
$ 2.05万 - 项目类别:
Regeneration of retinal function using human amnion cell-derived neural progenitors.
使用人羊膜细胞来源的神经祖细胞再生视网膜功能。
- 批准号:
23792013 - 财政年份:2011
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Human Amnion Cell Model for Investigation of Amniotic Fluid Volume
用于研究羊水量的人类羊膜细胞模型
- 批准号:
8242678 - 财政年份:2011
- 资助金额:
$ 2.05万 - 项目类别:
Retinal regeneration using human amnion cell-derived neural progenitors.
使用人羊膜细胞来源的神经祖细胞进行视网膜再生。
- 批准号:
21791716 - 财政年份:2009
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Young Scientists (B)